AI-Driven Prediction and Engineering of Protein Aggregation for Improved Stability and Manufacturability
AI-Driven Protein Aggregation Prediction
Protein aggregation is one of the leading causes of failure during protein discovery, development, manufacturing, and long-term storage.
Aggregation can reduce biological activity, complicate purification, limit expression yields, increase formulation challenges, and impact product quality.
Neoncorte Bio applies AI-driven protein engineering to predict aggregation propensity and support the design of proteins with improved stability, solubility, and manufacturability.
Why Protein Aggregation Matters
Aggregation affects virtually every stage of protein development.
Whether developing industrial enzymes, therapeutic antibodies, recombinant proteins, or diagnostic reagents, minimizing aggregation is essential for successful commercialization.
Early computational assessment can help identify high-risk protein variants before extensive laboratory investment.
Whether developing industrial enzymes, therapeutic antibodies, recombinant proteins, or diagnostic reagents, minimizing aggregation is essential for successful commercialization.
Early computational assessment can help identify high-risk protein variants before extensive laboratory investment.
Application Areas
-
Industrial Enzymes
Improve enzyme stability for demanding industrial operating conditions.
Benefit: Enhanced product robustness and operational lifetime. -
Antibody Engineering
Support optimization of monoclonal antibodies, bispecific antibodies, and antibody fragments.
Benefit: Reduced aggregation and improved formulation potential. -
Therapeutic Proteins
Identify aggregation-prone regions that may affect biologic development.
Benefit: Improved developability and manufacturing readiness. -
Recombinant Protein Production
Reduce aggregation that limits recombinant protein expression and purification.
Benefit: Higher production yields and improved manufacturability. -
Diagnostic Proteins
Improve stability of proteins used in diagnostic assays and laboratory reagents.
Benefit: More consistent product performance during storage and use.
Common Consequences of Protein Aggregation
Protein aggregation may contribute to:
- Reduced soluble expression
- Lower recombinant protein yield
- Loss of catalytic activity
- Reduced therapeutic potency
- Difficult purification
- Shortened shelf life
- Increased formulation complexity
- Manufacturing variability
- Poor freeze-thaw stability
- Reduced long-term storage stability
AI-Guided Protein Aggregation Prediction
Neoncorte Bio combines computational protein engineering with structural biology and machine learning to evaluate aggregation risk from protein sequence and structural features.
Our engineering workflow may incorporate:
- Protein sequence analysis
- Structure-informed modeling
- Aggregation propensity prediction
- Surface hydrophobicity analysis
- Electrostatic surface analysis
- Protein language models
- Machine learning
- Multi-objective optimization
- Design-Build-Test-Learn (DBTL) methodologies
- Predicted aggregation hotspots can guide targeted protein engineering and experimental validation.
Properties We Evaluate
Protein aggregation analysis may include assessment of:
- Aggregation propensity
- Solubility
- Surface hydrophobicity
- Charge distribution
- Structural stability
- Thermal stability
- Freeze-thaw stability
- Manufacturability
- Recombinant expression potential
- Sequence liabilities
- Developability
- Engineering recommendations are tailored to the target protein and intended application.
Design-Build-Test-Learn (DBTL) Integration
Aggregation prediction is most effective when incorporated into iterative protein engineering.
Neoncorte Bio supports:
- Protein sequence analysis
- AI-guided aggregation assessment
- Candidate prioritization
- Protein engineering
- Experimental validation
- Machine learning model refinement
- Successive Design-Build-Test-Learn (DBTL) cycles
What Neoncorte Bio Delivers
- AI-guided protein aggregation prediction
- Aggregation hotspot identification
- Solubility assessment
- Structure-informed protein engineering
- Multi-parameter protein optimization
- Developability analysis
- Design-Build-Test-Learn (DBTL) workflows
- Confidential B2B protein engineering partnerships
Who We Work With
- Biopharmaceutical companies
- Antibody discovery companies
- Industrial biotechnology companies
- Enzyme manufacturers
- Diagnostic developers
- Synthetic biology startups
- CDMOs and CROs
- Academic research organizations
Frequently Asked Questions (FAQs)
Our platform harnesses advanced artificial intelligence and machine learning to design, optimize, and engineer proteins tailored to your specific requirements. Whether you need improved enzyme efficiency, novel protein functions, or tailored biotherapeutics, our solutions streamline the protein design process and reduce time-to-market.
Our services are ideal for biotechnology and pharmaceutical companies, academic research labs, industrial manufacturers, and any organization involved in protein-based product development. Applications include enzyme optimization, biocatalyst development, therapeutic protein design, and more.
The process begins with your input data, such as protein sequences, structural information, and desired functional attributes. Our AI algorithms then generate a library of potential protein variants and use predictive modeling to evaluate their stability, activity, and specificity. The top candidates are ranked and provided for further experimental validation, thereby reducing the number of required lab iterations.
Our platform is versatile and can be applied to a wide range of proteins, including enzymes, structural proteins, and therapeutic proteins. We can optimize existing proteins or design novel ones for applications in catalysis, biopharmaceuticals, diagnostics, and more.
Absolutely. We work closely with you to tailor our AI models and algorithms to your target proteins and desired outcomes. This includes integrating proprietary data and fine-tuning parameters to ensure that our platform delivers the most relevant and high-performing protein candidates for your application.
Our platform offers robust API support and standard data export formats (e.g., CSV, JSON) to seamlessly integrate with your Laboratory Information Management Systems (LIMS) and other data analytics pipelines. We also provide comprehensive onboarding and training to ensure a smooth adoption process.
Our models are trained on extensive datasets of protein interactions, structural data, and experimental results. We continuously refine our algorithms with real-world feedback to improve prediction accuracy. While our computational predictions are highly reliable, we recommend subsequent in vitro or in vivo validation to confirm the performance of the engineered proteins.
Yes, we provide collaborative support throughout the validation process. Our team can help design proof-of-concept studies and coordinate with your wet lab partners to verify the performance of our predicted protein variants.
We offer flexible pricing models based on the scope and duration of your project. Options include subscription-based plans for ongoing R&D, as well as project-specific pricing for one-off protein engineering campaigns. Please contact us for a personalized consultation and detailed quote.
Our dedicated customer support team is available to assist you at every stage—from initial onboarding and technical training to troubleshooting and ongoing optimization. We offer support via email, phone, and live chat, along with detailed documentation and a comprehensive FAQ section.
Reduce Aggregation Risk Early in Protein Development
Contact us to discuss your protein aggregation prediction project
Neoncorte Bio
Where AI Meets Biotechnology
Neoncorte Bio is at the forefront of the convergence between artificial intelligence and enzyme engineering. Our team comprises experts in computational biology, bioinformatics, and machine learning, all driven by a mission to accelerate innovation in enzyme design. By leveraging our advanced AI models, we provide unparalleled solutions that enhance efficiency, reduce costs, and push the boundaries of what's possible in enzyme engineering
Proud Member of Leading Global AI Programs
Neoncorte Bio is part of the NVIDIA Inception and Nebius for Startups programs — two of the world’s leading ecosystems for high-performance AI innovation. These partnerships strengthen our ability to deliver next-generation AI-driven protein, enzyme, and aptamer engineering.
-
As a member of NVIDIA Inception, Neoncorte Bio gains access to cutting-edge GPU technologies, expert guidance, and a global AI ecosystem that supports companies from prototype to production. The program empowers us to explore new AI opportunities and build high-performance biological design pipelines powered by NVIDIA’s world-class platform. -
Through Nebius for Startups, we gain access to high-performance compute infrastructure optimized for large-scale AI workloads, along with hands-on technical guidance and a strong community of innovative AI companies. Nebius enables us to train and deploy complex biological models more efficiently — accelerating enzyme, protein, and aptamer design while supporting rapid scaling of our R&D pipelines.
Publications
Scientific Publication of Neoncorte Bio Team
- Modification of natural enzymes to introduce new properties and enhance existing ones is a central challenge in bioengineering. This study is focused on the development of Taq polymerase mutants that show enhanced reverse transcriptase (RTase) activity while retaining other desirable properties such as fidelity, 5′-3′ exonuclease activity, effective deoxyuracil incorporation, and tolerance to locked nucleic acid (LNA)-containing substrates.
- The transcriptomic data are being frequently used in the research of biomarker genes of different diseases and biological states. The most common tasks there are the data harmonization and treatment outcome prediction. Both of them can be addressed via the style transfer approach. Either technical factors or any biological details about the samples which we would like to control (gender, biological state, treatment, etc.) can be used as style components.
- List of all Neoncorte Bio publications dedicated to Molecular Biology, Biotechnology, Artificial Intelligence and Artificial Neural Networks, published mostly by Nikolay Russkikh, CEO of Neoncorte Bio
Our Expertise in Action
With extensive experience in AI applications and software engineering tailored to the life sciences, we specialize in solving complex challenges and delivering innovative solutions for our customers. Our work demonstrates a deep understanding of cutting-edge technologies and their application in the real world.
Here are examples of the types of projects we have successfully delivered:
Here are examples of the types of projects we have successfully delivered:
- Automated NGS Data Analysis:Designed a production-grade solution for the automated processing, annotation, and analysis of Next-Generation Sequencing (NGS) data.
- Single-Cell Data Integration:Built state-of-the-art tools for integrating multimodal single-cell data, achieving recognition for technical excellence.
- Metagenomic Classification Algorithms:Developed advanced methods for classifying sequencing reads in metagenomics research.
- High-Throughput Image Processing Pipelines:Engineered an efficient pipeline to process millions of sequencing images with exceptional accuracy.
- Cell Counting via AI:Created a computer vision solution for precise cell counting in microphotography images, streamlining data analysis.
Get in touch with our team
Phone: +1-503-754-3958
Email: contact@neoncorte.com
Email: contact@neoncorte.com
© All Rights Reserved. Neoncorte Bio. 2024-2026
contact@neoncorte.com
contact@neoncorte.com